LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.
| Revenue (TTM) | $1.43B |
| Gross Profit (TTM) | $972.66M |
| EBITDA | $262.49M |
| Operating Margin | 14.40% |
| Return on Equity | 9.54% |
| Return on Assets | 5.27% |
| Revenue/Share (TTM) | $26.25 |
| Book Value | $22.06 |
| Price-to-Book | 3.35 |
| Price-to-Sales (TTM) | 2.83 |
| EV/Revenue | 2.692 |
| EV/EBITDA | 17.14 |
| Quarterly Earnings Growth (YoY) | -45.60% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $54.93M |
| Float | $54.68M |
| % Insiders | 0.37% |
| % Institutions | 112.27% |
Volatility is currently contracting